Altre lingue Shenyang Xingqi Pharmaceutical Co.,Ltd.

Azioni

300573

CNE100002DV1

Prezzo di chiusura Shenzhen S.E. Altri mercati azionari 00:00:00 08/07/2024			Variaz. 5gg	Var. 1 gen.
153,2 ^CNY	-5,75%		-6,61%	+17,61%

26/04	L'utile di Shenyang Xingqi Pharmaceutical nel primo trimestre è aumentato dell'80%	MT
25/04	Shenyang Xingqi Pharmaceutical Co.,Ltd. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Space Peptides announced that it has received funding from Humanwell Healthcare Co.,Ltd., Shenyang Xingqi Pharmaceutical Co.,Ltd., Xiamen Furuier Pharmaceutical Co., Ltd., Purple Knight Capital and other investors	22/05
Shenyang Xingqi Pharmaceutical Co.,Ltd. Announces Cash Dividend for 2023, Payable May 22, 2024	15/05
Shenyang Xingqi Pharmaceutical's Q1 Profit Jumps 80%	26/04
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	18/04
Xingqi Pharma Gets Nod to Market Atropine Sulfate Eye Drop; Shares Up 3%	13/03
Shenyang Xingqi Pharmaceutical Co.,Ltd. Approves Board Elections	08/01
Shenyang Xingqi Pharmaceutical Co.,Ltd.(SZSE:300573) added to Shenzhen Stock Exchange Component Index	12/12
Shenyang Xingqi Pharmaceutical Co.,Ltd.(SZSE:300573) added to Shenzhen Stock Exchange Component A Share Index	12/12
Xingqi Pharmaceutical's Diquafosol Sodium Eye Drops Bags China's Centralized Drug Bid	08/11
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23/10/23
Shenyang Xingqi Pharmaceutical Co.,Ltd. Announces Interim Dividend on A Shares for the Year 2023, Payable on 22 September 2023	18/09/23
Shenyang Xingqi Pharmaceutical Co.,Ltd Approves Cash Interim Profit Distribution Plan for 2023	14/09/23
Shenyang Xingqi Pharmaceutical Co.,Ltd. Proposes Interim Dividend for the First Half of 2023	29/08/23
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23
Xingqi Pharmaceutical Enrolls First Subject for Phase 4 Trial of Eye Drops	17/08/23
Shenyang Xingqi Pharmaceutical Co.,Ltd Approves Cash Dividend for the Year 2022, Payable on 22 May 2023	12/05/23
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/04/23
Shenyang Xingqi Pharmaceutical Co.,Ltd Proposes Final Dividend for 2022	20/04/23
Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	19/04/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Shenyang Xingqi Pharmaceutical Co.,Ltd.

Azioni

300573

CNE100002DV1

Altre lingue

Filtri